Official-source baseline for Abeona Therapeutics using SEC submissions, SEC company facts, the FY2025 10-K, latest available 10-Q, filed FY2025 results release, filed launch update, 2026 proxy materials, and FDA product approval sources.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
